North America Pharmaceutical Fill and Finish Outsourcing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By State of Finished Product (Solids, Semi-solids, and Liquids), Content (Organic Substances Isolated from Animal Origin, Organic Substances Isolated from Microorganisms, and Inorganic Substances)

TIPRE00027254 | Pages: 126 | Pharmaceuticals | Feb 2022 | Type: Regional | Status: Published

The North America pharmaceutical fill and finish outsourcing market is expected to reach US$ 1,741.0 million by 2028 from US$ 1,188.8 million in 2021. The market is estimated to grow at a CAGR of 5.6% from 2021–2028.

 

The market for biopharmaceuticals continues to expand in North America, and acts as a prime growth driver for the pharmaceutical industry. Over the next significant years, the biopharmaceuticals market continues to provide significant growth opportunities for the pharmaceutical market. As a result of the escalated flow of capital into the sector, biotech companies are becoming more discerning about the investors with whom they choose to partner, taking a view of longer-term than might have previously been the case in a sector in which the cash burn rate from R&D is well known. During the past two years, fundraising and investment in biopharmaceuticals have outstretched record levels. Private investments have been led by healthtech, and pharmaceutical companies, and the first half of 2020 saw a common year-over-year rise in biopharma investment. This is being driven by factors such as a strong pipeline of innovative technology, new drugs in advanced R&D stages, vigorous demand from investors, who seeks to grasp the higher returns on investment associated with the industry and the need for pharma companies to reload their pipeline to secure future revenue.  For Instance: in March 2020, Thermo Fisher Scientific Inc. invested nearly US$ 475 million as a biopharma investment in the expansion of biologics, drug product development, cell and gene therapy and to increase its commercial capabilities in North America.

 

The outbreak of COVID-19 pandemic in China affected significantly the supply of finished drugs and APIs to the US. For records, an estimated 83% of Chinese import lines to the US were human finished dosage forms, while 7.5% were APIs in 2018. Also, factory lockdowns in China and logistics delays due to coronavirus measures at ports would mean lower production and delays in shipping of APIs to US manufacturers. With the coronavirus spreading, the US based pharmaceutical companies faced cost escalation. Therefore, demand for CMOs along with pharmaceutical companies in North America region was high and is contemplating to get approval for the clinical trial vaccines to prevent COVID-19 infection.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the pharmaceutical fill and finish outsourcing market. The North America pharmaceutical fill and finish outsourcing market is expected to grow at a good CAGR during the forecast period.

 

 North America Pharmaceutical Fill And Finish Outsourcing Market Revenue and Forecast to 2028 (US$ Million)

 

North America Pharmaceutical Fill And Finish Outsourcing Market Segmentation   

By State of Finished Product

  • Solids
  • Semi-Liquid
  • Liquid

By Content

  • Organic Substances Isolated from Animal Origin
  • Organic Substances Isolated from Microorganisms 
  • Inorganic Substances

By Country

  • North America
  • US
  • Canada
  • Mexico

Companies Mentioned

  • Abbott
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Dr. Reddy's Laboratories
  • Sun Pharmaceutical Industries Ltd
  • Piramal Enterprises Ltd.
  • MabPlex International Ltd
  • WOCKHARDT
  • Cytovance Biologics
  • Thermo Fisher Scientific Inc. (Patheon N.V)
  • Boehringer Ingelheim International GmbH        

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        By State of Finished Product

1.3.2        By Content

1.3.3        By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Pharmaceutical Fill and Finish Outsourcing Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           Pharmaceutical Fill and Finishing Outsourcing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Investment in Biopharmaceutical Sector

5.1.2        Elevating Demand for Biologics

5.2         Market Restraints

5.2.1        Upsurging Competition in Contract Manufacturing Industry

5.3         Market Opportunities

5.3.1        Growing Market for Biotherapeutics

5.4         Future Trends

5.4.1        Rising Market Consolidation

5.5         Impact Analysis

6.           Pharmaceutical Fill and Finish Outsourcing Market– North America Analysis

6.1         North America Pharmaceutical Fill and Finish Outsourcing Market, By Geography - Forecast and Analysis

7.           North America Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts To 2028– by State of the Finished Product

7.1         Overview

7.2         North America Pharmaceutical Fill and Finish Outsourcing Market, By State of the Finished Product, 2020 & 2028 (%)

7.3         Solids

7.3.1        Overview

7.3.2        Solids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Semisolids

7.4.1        Overview

7.4.2        Semi-solids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Liquids

7.5.1        Overview

7.5.2        Liquids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

8.           Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts To 2028 – Content

8.1         Overview

8.2         North America Pharmaceutical Fill and Finish Outsourcing Market Share by Content - 2020 & 2028 (%)

8.3         Organic Substances Isolated from Animal Origin

8.3.1        Overview

8.3.2        Organic Substances Isolated from Animal Origin: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecast to 2028 (US$ Million)

8.4         Organic Substances Isolated from Microorganisms

8.4.1        Overview

8.4.2        Organic Substances Isolated from Microorganisms: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecast to 2028 (US$ Million)

8.5         Inorganic Substances

8.5.1        Overview

8.5.2        Inorganic Substances: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecast to 2028 (US$ Million)

9.           Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 – Geographical Analysis

9.1         North America: Pharmaceutical Fill and Finish Outsourcing Market

9.1.1        Overview

9.1.2        North America: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3        North America: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products, 2019–2028 (US$ Million)

9.1.4        North America: Pharmaceutical Fill and Finish Outsourcing Market, by Content, 2019–2028 (US$ Million)

9.1.5        North America: Pharmaceutical Fill and Finish Outsourcing Market, by Country, 2021 & 2028 (%)

9.1.5.1          US: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.1          Overview

9.1.5.1.2          US: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.3          US: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products, 2019–2028 (US$ Million)

9.1.5.1.4          US: Pharmaceutical Fill and Finish Outsourcing Market, by Content, 2019–2028 (US$ Million)

9.1.5.2          Canada: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.1          Overview

9.1.5.2.2          Canada: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.3          Canada: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products, 2019–2028 (US$ Million)

9.1.5.2.4          Canada: Pharmaceutical Fill and Finish Outsourcing Market, by Content, 2019–2028 (US$ Million)

9.1.5.3          Mexico: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.1          Overview

9.1.5.3.2          Mexico: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.3          Mexico: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products, 2019–2028 (US$ Million)

9.1.5.3.4          Mexico: Pharmaceutical Fill and Finish Outsourcing Market, by Content, 2019–2028 (US$ Million)

10.        Impact Of COVID-19 Pandemic on Pharmaceutical Fill and Finish Outsourcing Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Pharmaceutical Fill and Finish Outsourcing Market–Industry Landscape

11.1      Overview

11.2      Growth Strategies in the Pharmaceutical Fill and Finish Outsourcing Market (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic Developments

11.4.1     Overview

12.        Company Profiles

12.1      Abbott

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Dr. Reddy's Laboratories

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Sun Pharmaceutical Industries Ltd

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Piramal Enterprises Ltd.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      MabPlex International Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      WOCKHARDT

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Cytovance Biologics

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Thermo Fisher Scientific Inc. (Patheon N.V)

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Boehringer Ingelheim International GmbH

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products – Revenue and Forecast to 2028 (US$ Million)

Table 2.             North America Pharmaceutical Fill and Finish Outsourcing Market, by Content– Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Pharmaceutical Fill and Finish Outsourcing Market, by Content– Revenue and Forecast to 2028  (US$ Million)

Table 5.             Canada: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Pharmaceutical Fill and Finish Outsourcing Market, by Content– Revenue and Forecast to 2028  (US$ Million)

Table 7.             Mexico: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico Pharmaceutical Fill and Finish Outsourcing Market, by Content– Revenue and Forecast to 2028  (US$ Million)

Table 9.             Organic Developments in the Pharmaceutical Fill and Finish Outsourcing Market

Table 10.          Inorganic Developments in the Pharmaceutical Fill and Finish Outsourcing Market

Table 11.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           Pharmaceutical Fill and Finish Outsourcing Market Segmentation

Figure 2.           North America Pharmaceutical Fill and Finish Outsourcing Market Overview

Figure 3.           Liquid Segment Held Largest Share of State of Finished Product Segment in Pharmaceutical Fill and Finish Outsourcing Market

Figure 4.           Canada is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Pharmaceutical Fill and Finish Outsourcing Market, Industry Landscape

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Number of Approvals for NDA & BLA (2015 to 2020)

Figure 9.           Impact Analysis of Drivers and Restraints Pertaining to Pharmaceutical Fill and Finishing Outsourcing Market

Figure 10.        North America Pharmaceutical Fill and Finish Outsourcing Market – By Geography Forecast and Analysis – 2020 - 2028

Figure 11.        North America Pharmaceutical Fill and Finish Outsourcing Market, by State of the Finished Product, 2020 & 2028 (%)

Figure 12.        Solids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Semi-solids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Liquids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        North America Pharmaceutical Fill and Finish Outsourcing Market Share by Content - 2020 & 2028 (%)

Figure 16.        Organic Substances Isolated from Animal Origin: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        Organic Substances Isolated from Microorganisms: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18.        Inorganic Substances: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        North America: Pharmaceutical Fill and Finish Outsourcing Market, by Key Country – Revenue (2021) (US$ Million)

Figure 20.        North America Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America: Pharmaceutical Fill and Finish Outsourcing Market, by Country, 2021 & 2028 (%)

Figure 22.        US: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Canada: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Mexico: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 26.        Growth Strategies in the Pharmaceutical Fill and Finish Outsourcing Market (%)

 

 

  1. Abbott
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Dr. Reddy's Laboratories
  4. Sun Pharmaceutical Industries Ltd
  5. Piramal Enterprises Ltd.
  6. MabPlex International Ltd
  7. WOCKHARDT
  8. Cytovance Biologics
  9. Thermo Fisher Scientific Inc. (Patheon N.V)
  10. Boehringer Ingelheim International GmbH          
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America pharmaceutical fill and finish outsourcing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America pharmaceutical fill and finish outsourcing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000